2025
SJR Q3
JCR Q4 · 1
233 matched articles
SCIE
Journal detail
Medical Hypotheses
- Publisher
- Churchill Livingstone
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
0306987715322777
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,255
- Quartile Q3
- H-Index 118
- Cites/doc 0,96
- Docs (3y) 511
- Cites (3y) 441
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 1
- 5Y JIF 1,6
- JCI 0,23
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Medicine (miscellaneous) Q3
Areas
- Medicine
WoS categories
- Medicine, Research & Experimental
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q4 | 0,255 | 1 | 1,6 | 0,23 | Q4 | 118 |
| 2024 | Q3 | Q4 | 0,387 | 0,8 | 1,9 | 0,46 | Q3 | 112 |
| 2023 | Q2 | Q3 | 0,587 | 2,1 | 2,4 | 0,85 | Q2 | 112 |
| 2022 | Q2 | Q2 | 0,619 | 4,7 | 3 | 0,84 | Q2 | 112 |
| 2021 | Q2 | Q2 | 0,569 | 4,4 | 3,1 | 0,77 | Q2 | 112 |
| 2020 | Q3 | Q4 | 0,441 | 1,5 | 1,6 | 0,47 | Q3 | 112 |
| 2019 | Q3 | Q4 | 0,427 | 1,4 | 1,3 | 0,53 | Q3 | 112 |
| 2018 | — | Q4 | — | 1,3 | 1,2 | 0,5 | Q3 | — |
| 2017 | Q3 | Q4 | 0,443 | 1,1 | 1,2 | 0,48 | Q3 | 112 |
| 2016 | Q2 | Q4 | 0,455 | 1,1 | 1,1 | — | — | 112 |
| 2015 | Q2 | Q4 | 0,493 | 1,1 | 1,1 | — | — | 112 |
| 2014 | Q2 | Q4 | 0,462 | 1,1 | 1,1 | — | — | 112 |
| 2013 | Q2 | Q4 | 0,468 | 1,2 | 1,2 | — | — | 112 |
| 2012 | Q2 | Q4 | 0,42 | 1,1 | 1,2 | — | — | 112 |
| 2011 | Q2 | Q3 | 0,383 | 1,1 | 1,2 | — | — | 112 |
| 2010 | Q2 | Q3 | 0,416 | 1,4 | 1,3 | — | — | 112 |
| 2009 | — | Q3 | — | 1,4 | 1,3 | — | — | — |
| 2008 | — | Q3 | — | 1,4 | 1,2 | — | — | — |
| 2007 | — | Q3 | — | 1,3 | 1,1 | — | — | — |
| 2006 | — | Q3 | — | 1,3 | — | — | — | — |
| 2005 | — | Q4 | — | 0,9 | — | — | — | — |
| 2004 | — | Q4 | — | 0,6 | — | — | — | — |
| 2003 | — | Q4 | — | 0,7 | — | — | — | — |
| 2002 | — | Q4 | — | 0,7 | — | — | — | — |
| 2001 | — | Q3 | — | 0,7 | — | — | — | — |
| 2000 | — | Q3 | — | 0,8 | — | — | — | — |
| 1999 | — | Q3 | — | 0,7 | — | — | — | — |
| 1998 | — | Q3 | — | 0,6 | — | — | — | — |
| 1997 | — | Q3 | — | 0,5 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q4 | 155/191 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 165/195 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 118/189 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 54/136 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 65/139 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 123/140 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 120/139 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 113/136 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 113/133 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 105/128 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 100/124 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 104/123 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 94/124 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 94/121 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 83/112 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 70/106 |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 64/93 |
| 2008 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 57/83 |
| 2007 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 60/81 |
| 2006 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 50/76 |
| 2005 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 57/72 |
| 2004 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 61/71 |
| 2003 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 59/72 |
| 2002 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 60/74 |
| 2001 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 56/75 |
| 2000 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 52/74 |
| 1999 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 52/76 |
| 1998 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 42/72 |
| 1997 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 43/61 |